Skip to content

Muscle strength and body function confirmation test by functional material supplementation-double-blind parallel group comparison test (RCT test) - "double-blind parallel group comparison test

Muscle strength and body function confirmation test by functional material supplementation-double-blind parallel group comparison test (RCT test) - "double-blind parallel group comparison test - Muscle strength and body function confirmation test by functional material supplementation (RCT test)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030897
Enrollment
60
Registered
2019-05-30
Start date
2018-01-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake of HMBCa for 1.5g/day and 12 weeks Intake of HMBCa for 2.0g/day and 12 weeks Intake of placebo for 12 weeks

Sponsors

Akanuma Surgery Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [1] Males and females aged 20-60 years [2] Subjects equal to or more than 22 and less than 30 kg/m^2 of BMI and do not fall under the diagnostic criteria of metabolic syndrome [3] Subjects whose fat mass is over 20 [4] Subjects who are healthy and are currently not treating any serious disease [5] Subjects who can visit facilities designated at the scheduled arrival date [6] Subjects who agreed in writing after fully understanding the purpose and contents of this exam

Exclusion criteria

Exclusion criteria: [1] Subjects who routinely use amino acids or protein-reinforced foods or drinks for maintaining physical strength, improving exercise function or dieting [2] Subjects who have periodic exercise habits more than twice a week [3] Subjects who are difficult to participate in the examination due to liver, kidney, heart disease, respiratory disorder, endocrine disorder, metabolic disorder, neurological disorder, disturbance of consciousness, diabetes (according to the standards set by the Japan Diabetes Association) [4] Subjects who has a history of cardiovascular disease [5] Subjects who regularly use medicines that may affect this examination, health foods / supplements (including foods for specified health use, functional display foods and nutrient function foods) (However, ingestion can be stopped at the time of consent acquisition The person does not apply) [6] Subjects who are allergic to the test food [7] Subjects who has experienced mood disorder or condition deterioration due to blood collection in the past [8] Subjects who donated blood of 200 mL or more from the beginning of the test until the start of the test or those who have the schedule during the test period [9] Participating in other clinical trials or within 4 weeks after the examination [10] Alcohol drinkers and excessive smokers [11] Subjects whose diet is extremely irregular [12] Subjects who can not agree with the purpose of this test conducted in advance [13] Others who are deemed inappropriate for participation in this study by a doctor

Design outcomes

Primary

MeasureTime frame
Body weight, BMI, body fat percentage, muscle mass, body fat mass, limb muscle mass, waist size

Secondary

MeasureTime frame
Grip strength, One-leg standing duration with vision, One-leg standing duration with no vision, 10 m walking speed, Lower limb extensor strength, questionnaire

Countries

Japan

Contacts

Public ContactKousuke Kurose

Nakahara Co., Ltd R & D division

kousuke.kurose@nakahara2001.co.jp048-710-8877

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026